Male breAsT cAncer preDisposition Factor

CompletedOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

February 8, 2024

Primary Completion Date

February 6, 2025

Study Completion Date

February 6, 2025

Conditions
Breast Cancer
Interventions
OTHER

Questionnaire completion

"To meet the study's objective, patients will be asked to complete a questionnaire characterizing their environmental and psychosocial context.~The questionnaire is to be completed by the patients themselves, or by their trusted support person as recorded in their medical records (in the particular case of a deceased patient).~It is estimated that the questionnaire will take around 30 minutes to complete.~Data will also be collected from the medical records of included patients:~* Demographics~* Disease data"

Trial Locations (1)

Unknown

IUCT-O, Toulouse

All Listed Sponsors
collaborator

Ligue contre le cancer, France

OTHER

lead

Institut Claudius Regaud

OTHER

NCT06219187 - Male breAsT cAncer preDisposition Factor | Biotech Hunter | Biotech Hunter